Yoshitaka Shirasaki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yoshitaka Shirasaki has a total of 283 co-authors. Here are the top co-authors by number of shared publications:
- Mai Yamagishi
Live Cell Diagnosis, Ltd., Saitama, Japan
17 shared publications - Takashi Funatsu
Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan
15 shared publications Shuichi Shoji
Faculty of Science and Engineering, Waseda University, Okubo 3-4-1, Shinjuku, Tokyo 169-8555, Japan
10 shared publications- Keisuke Goda
Department of Chemistry, The University of Tokyo, Tokyo 113-0033, Japan
7 shared publications Nobutake Suzuki
Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo 113-0033, Japan
7 shared publications- Osamu Ohara
Department of Applied Genomics, Kazusa DNA Research Institute, 2-6-7 Kazusa-kamatari, Kisarazu, Chiba 292-0818, Japan
7 shared publications
Latest Publications
- Open Access
- 27 May 2026
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 158 (1) , 62-72
Differential responses of group 2 innate lymphoid cells and TH2 cells to benralizumab in severe asthma
- 27 May 2026
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 158 (1) , 62-72
Open AccessDifferential responses of group 2 innate lymphoid cells and TH2 cells to benralizumab in severe asthma
- Open Access
- 21 May 2026
- Published by Springer Nature in Communications Biology
- Vol. 9 (1)
Temporal control of Ninj1 activation determines cell-to-cell heterogeneity in IL-33 release
Interleukin-33 (IL-33), an IL-1 family cytokine, is released during cell damage. However, the mechanism underlying IL-33 release is not fully understood. Here, we generate IL-33-mCherry-expressing mouse cell lines to monitor IL-33 release at single cell resolution. During necroptosis, SYTOX uptake that represents loss of membrane integrity, and IL-33-mCherry release occur simultaneously, indicating that Mlkl-mediated damage causes immediate membrane rupture. In contrast, some apoptotic and pyroptotic cells exhibit delayed IL-33-mCherry release relative to SYTOX uptake, whereas in other cells, both events occur simultaneously. IL-33-mCherry release is only modestly affected by loss of Gsdmd or Gsdme but is markedly reduced in Ninjurin-1 (Ninj1) knockout cells. These findings indicate that Gasdermins act upstream, whereas Ninj1-mediated membrane rupture represents the principal mechanism of IL-33 release. The delay in IL-33-mCherry release in some cells implies that the activation of Ninj1 occurs with variable timing, thus contributing to cell-to-cell heterogeneity.
- 21 May 2026
- Published by Springer Nature in Communications Biology
- Vol. 9 (1)
Open AccessTemporal control of Ninj1 activation determines cell-to-cell heterogeneity in IL-33 release
Interleukin-33 (IL-33), an IL-1 family cytokine, is released during cell damage. However, the mechanism underlying IL-33 release is not fully understood. Here, we generate IL-33-mCherry-expressing mouse cell lines to monitor IL-33 release at single cell resolution. During necroptosis, SYTOX uptake that represents loss of membrane integrity, and IL-33-mCherry release occur simultaneously, indicating that Mlkl-mediated damage causes immediate membrane rupture. In contrast, some apoptotic and pyroptotic cells exhibit delayed IL-33-mCherry release relative to SYTOX uptake, whereas in other cells, both events occur simultaneously. IL-33-mCherry release is only modestly affected by loss of Gsdmd or Gsdme but is markedly reduced in Ninjurin-1 (Ninj1) knockout cells. These findings indicate that Gasdermins act upstream, whereas Ninj1-mediated membrane rupture represents the principal mechanism of IL-33 release. The delay in IL-33-mCherry release in some cells implies that the activation of Ninj1 occurs with variable timing, thus contributing to cell-to-cell heterogeneity.
- Open Access
- 18 February 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 1658
cGAS-IFN-I responses by extracting nuclear DNA from dying cells via nucleocytosis
Self-DNA triggers cGAS-STING-mediated type I interferon (IFN-I) to induce both protective and pathogenic immune responses; however, how self-DNA activates the cytosolic cGAS-STING pathway remains unclear. Here we show that the cGAS/STING/IFN-I axis is activated by self-DNA via a process termed ‘nucleocytosis’, in which nuclear DNA is extracted from dying cells by macrophages. Mechanistically, lysosomal malfunction, via both proton loss and palmitoyl-protein thioesterase 1 (PPT1) inhibition, triggers cell death and calreticulin accumulation in the nuclei. Live-cell imaging of secretion activity reveals that macrophages access the calreticulin-enriched nuclei of dying cells and extract DNA for cGAS-STING activation. Consistent with these findings, PPT1-targeting cationic amphiphilic drugs induce a cGAS-STING-dependent IFN-I response in vitro and in vivo. Our findings thus identify nucleocytosis as a macrophage function for nuclear DNA extraction and induction of the cGAS/IFN-I axis, and suggest that nucleocytosis-inducing cell death could be a druggable target for treating self-DNA-related inflammatory diseases.
- 18 February 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 1658
Open AccesscGAS-IFN-I responses by extracting nuclear DNA from dying cells via nucleocytosis
Self-DNA triggers cGAS-STING-mediated type I interferon (IFN-I) to induce both protective and pathogenic immune responses; however, how self-DNA activates the cytosolic cGAS-STING pathway remains unclear. Here we show that the cGAS/STING/IFN-I axis is activated by self-DNA via a process termed ‘nucleocytosis’, in which nuclear DNA is extracted from dying cells by macrophages. Mechanistically, lysosomal malfunction, via both proton loss and palmitoyl-protein thioesterase 1 (PPT1) inhibition, triggers cell death and calreticulin accumulation in the nuclei. Live-cell imaging of secretion activity reveals that macrophages access the calreticulin-enriched nuclei of dying cells and extract DNA for cGAS-STING activation. Consistent with these findings, PPT1-targeting cationic amphiphilic drugs induce a cGAS-STING-dependent IFN-I response in vitro and in vivo. Our findings thus identify nucleocytosis as a macrophage function for nuclear DNA extraction and induction of the cGAS/IFN-I axis, and suggest that nucleocytosis-inducing cell death could be a druggable target for treating self-DNA-related inflammatory diseases.
- Open Access
- 22 December 2025
- Published by Springer Nature in Cell Death & Disease
- Vol. 16 (1)
Resident alveolar macrophages are highly susceptible to the induction of RIPK1/RIPK3-mediated necroptosis which promote efficient pulmonary immune response
Alveolar macrophages (AMs) play a crucial role in protecting the lungs from pathogens by inducing immunogenic cell death (ICD). However, the type of cell death that effectively induces protective immunity remains to be fully understood. In our investigation of the mechanisms regulating AM activation and lung immune responses, we found that AMs are highly susceptible to necroptosis, a form of ICD. Treatment with pan-caspase inhibitors, such as emricasan or benzyloxycarbonyl-Val-Ala-Asp(OMe)-fluoromethyl ketone (ZVAD-fmk), directly induced cell death in AMs, resulting in the release of interleukin (IL)-1α in the lungs. This phenomenon was not observed in mouse lung fibroblasts or bone marrow-derived macrophages, indicating a cell type-specific sensitivity. The process was mediated by receptor-interacting protein kinase (RIPK)1 and RIPK3, and notably occurred without any additional necroptosis triggers such as tumor necrosis factor (TNF) or second mitochondria-derived activator of caspase (SMAC) mimetics. Moreover, activation of the RIPK1–RIPK3 signaling pathway not only triggered necroptosis but also promoted IL-1α production and release. These responses were absent in AMs lacking functional RIPK1 kinase activity or deficient in RIPK3. Importantly, RIPK1/RIPK3-mediated cell death and IL-1α release were sufficient to trigger lung immune responses, as shown by increased antigen-specific IgG and IgA production, which was significantly decreased in mice deficient in necroptosis or lacking the IL-1 receptor. Taken together, these findings demonstrate that the pan-caspase inhibitor emricasan induces necroptotic cell death in AMs and may act as a promising AM-targeted adjuvant to enhance lung-specific acquired immunity.
- 22 December 2025
- Published by Springer Nature in Cell Death & Disease
- Vol. 16 (1)
Open AccessResident alveolar macrophages are highly susceptible to the induction of RIPK1/RIPK3-mediated necroptosis which promote efficient pulmonary immune response
Alveolar macrophages (AMs) play a crucial role in protecting the lungs from pathogens by inducing immunogenic cell death (ICD). However, the type of cell death that effectively induces protective immunity remains to be fully understood. In our investigation of the mechanisms regulating AM activation and lung immune responses, we found that AMs are highly susceptible to necroptosis, a form of ICD. Treatment with pan-caspase inhibitors, such as emricasan or benzyloxycarbonyl-Val-Ala-Asp(OMe)-fluoromethyl ketone (ZVAD-fmk), directly induced cell death in AMs, resulting in the release of interleukin (IL)-1α in the lungs. This phenomenon was not observed in mouse lung fibroblasts or bone marrow-derived macrophages, indicating a cell type-specific sensitivity. The process was mediated by receptor-interacting protein kinase (RIPK)1 and RIPK3, and notably occurred without any additional necroptosis triggers such as tumor necrosis factor (TNF) or second mitochondria-derived activator of caspase (SMAC) mimetics. Moreover, activation of the RIPK1–RIPK3 signaling pathway not only triggered necroptosis but also promoted IL-1α production and release. These responses were absent in AMs lacking functional RIPK1 kinase activity or deficient in RIPK3. Importantly, RIPK1/RIPK3-mediated cell death and IL-1α release were sufficient to trigger lung immune responses, as shown by increased antigen-specific IgG and IgA production, which was significantly decreased in mice deficient in necroptosis or lacking the IL-1 receptor. Taken together, these findings demonstrate that the pan-caspase inhibitor emricasan induces necroptotic cell death in AMs and may act as a promising AM-targeted adjuvant to enhance lung-specific acquired immunity.
- 11 November 2025
- Published by Springer Nature in Nature Immunology
- Vol. 26 (12) , 2148-2158
Single-cell analysis reveals cell death as driver of NLRP3-mediated secretion of IL-1β in human monocytes
Interleukin-1β (IL-1β) is a key proinflammatory cytokine with critical roles in infections and inflammatory diseases, yet the mechanisms regulating its release from human monocytes remain unclear. Here we used a suite of single-cell approaches, including integrated live-cell imaging of secretion and cell fate, flow cytometry and high-content imaging, to investigate IL-1β secretion dynamics in lipopolysaccharide-stimulated primary human peripheral blood CD14+ monocytes. We found marked heterogeneity: a large fraction of cells remained viable and contributed negligibly to IL-1β secretion, challenging established models. Instead, a small subset (5–10%) undergoing canonical NLRP3 inflammasome activation and GSDMD-dependent pyroptosis produced the majority of secreted IL-1β, with a smaller contribution from apoptotic cells transitioning to secondary necrosis. Single-cell profiling of CD14+ monocytes from patients with cryopyrin-associated periodic syndrome confirmed lytic cell death as the driver of pathological IL-1β release. These findings redefine IL-1β as a damage-associated molecular pattern, secreted predominantly by dying monocytes.
- 11 November 2025
- Published by Springer Nature in Nature Immunology
- Vol. 26 (12) , 2148-2158
Single-cell analysis reveals cell death as driver of NLRP3-mediated secretion of IL-1β in human monocytes
Interleukin-1β (IL-1β) is a key proinflammatory cytokine with critical roles in infections and inflammatory diseases, yet the mechanisms regulating its release from human monocytes remain unclear. Here we used a suite of single-cell approaches, including integrated live-cell imaging of secretion and cell fate, flow cytometry and high-content imaging, to investigate IL-1β secretion dynamics in lipopolysaccharide-stimulated primary human peripheral blood CD14+ monocytes. We found marked heterogeneity: a large fraction of cells remained viable and contributed negligibly to IL-1β secretion, challenging established models. Instead, a small subset (5–10%) undergoing canonical NLRP3 inflammasome activation and GSDMD-dependent pyroptosis produced the majority of secreted IL-1β, with a smaller contribution from apoptotic cells transitioning to secondary necrosis. Single-cell profiling of CD14+ monocytes from patients with cryopyrin-associated periodic syndrome confirmed lytic cell death as the driver of pathological IL-1β release. These findings redefine IL-1β as a damage-associated molecular pattern, secreted predominantly by dying monocytes.
- Open Access
- 29 July 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 6617
Senescence-associated lysosomal dysfunction impairs cystine deprivation-induced lipid peroxidation and ferroptosis
Senescent cells, characterized by irreversible cell cycle arrest and inflammatory factor secretion, promote various age-related pathologies. Senescent cells exhibit resistance to ferroptosis, a form of iron-dependent cell death; however, the underlying mechanisms remain unclear. Here, we discovered that lysosomal acidity was crucial for lipid peroxidation and ferroptosis induction by cystine deprivation. In senescent cells, lysosomal alkalinization causes the aberrant retention of ferrous iron in lysosomes, resulting in resistance to ferroptosis. Treatment with the V-ATPase activator EN6 restored lysosomal acidity and ferroptosis sensitivity in senescent cells. A similar ferroptosis resistance mechanism involving lysosomal alkalinization was observed in pancreatic cancer cell lines. EN6 treatment prevented pancreatic cancer development in xenograft and Kras mutant mouse models. Our findings reveal a link between lysosomal dysfunction and the regulation of ferroptosis, suggesting a therapeutic strategy for the treatment of age-related diseases.
- 29 July 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 6617
Open AccessSenescence-associated lysosomal dysfunction impairs cystine deprivation-induced lipid peroxidation and ferroptosis
Senescent cells, characterized by irreversible cell cycle arrest and inflammatory factor secretion, promote various age-related pathologies. Senescent cells exhibit resistance to ferroptosis, a form of iron-dependent cell death; however, the underlying mechanisms remain unclear. Here, we discovered that lysosomal acidity was crucial for lipid peroxidation and ferroptosis induction by cystine deprivation. In senescent cells, lysosomal alkalinization causes the aberrant retention of ferrous iron in lysosomes, resulting in resistance to ferroptosis. Treatment with the V-ATPase activator EN6 restored lysosomal acidity and ferroptosis sensitivity in senescent cells. A similar ferroptosis resistance mechanism involving lysosomal alkalinization was observed in pancreatic cancer cell lines. EN6 treatment prevented pancreatic cancer development in xenograft and Kras mutant mouse models. Our findings reveal a link between lysosomal dysfunction and the regulation of ferroptosis, suggesting a therapeutic strategy for the treatment of age-related diseases.
- Open Access
Early-peaking caspase-7 activity at the plasma membrane drives apoptotic phosphatidylserine exposure
Apoptosis is an immunologically silent form of regulated cell death executed by caspase 1 . Caspase cleaves hundreds of substrates throughout the cell to regulate apoptotic processes 2 , including phosphatidylserine (PS) externalization 3–5 . However, spatio-temporal regulation of caspase activity in dying cells remains unclear. Here, we show that caspase activity peaks earlier at the plasma membrane (PM) during apoptosis by establishing a Dual Förster resonance energy transfer (Dual FRET) imaging system that combines subcellularly targeted FRET-based caspase biosensors with a cytosolic reference counterpart 6,7 . Genetic analysis identified caspase-7, an executioner caspase considered an inefficient backup for caspase-3, the major executioner caspase 8,9 , as a caspase responsible for the E arly- P eaking C aspase A ctivity at the P M (EP-CAP). Mechanistically, EP-CAP is mediated via electrostatic interactions between PS in the inner leaflet of the PM and polybasic residues in the N-terminal intrinsically disordered region (IDR) of caspase-7, which are liberated by the caspase-mediated removal of polyacidic residues. Physiologically, EP-CAP facilitates the efficient cleavage of phospholipid scramblases for the rapid externalization of PS and subsequent efferocytosis. Accordingly, we propose that caspase-7, but not caspase-3, is a bona fide immunologically silent death caspase reinforcing the non-inflammatory nature of apoptosis via EP-CAP.
Open AccessEarly-peaking caspase-7 activity at the plasma membrane drives apoptotic phosphatidylserine exposure
Apoptosis is an immunologically silent form of regulated cell death executed by caspase 1 . Caspase cleaves hundreds of substrates throughout the cell to regulate apoptotic processes 2 , including phosphatidylserine (PS) externalization 3–5 . However, spatio-temporal regulation of caspase activity in dying cells remains unclear. Here, we show that caspase activity peaks earlier at the plasma membrane (PM) during apoptosis by establishing a Dual Förster resonance energy transfer (Dual FRET) imaging system that combines subcellularly targeted FRET-based caspase biosensors with a cytosolic reference counterpart 6,7 . Genetic analysis identified caspase-7, an executioner caspase considered an inefficient backup for caspase-3, the major executioner caspase 8,9 , as a caspase responsible for the E arly- P eaking C aspase A ctivity at the P M (EP-CAP). Mechanistically, EP-CAP is mediated via electrostatic interactions between PS in the inner leaflet of the PM and polybasic residues in the N-terminal intrinsically disordered region (IDR) of caspase-7, which are liberated by the caspase-mediated removal of polyacidic residues. Physiologically, EP-CAP facilitates the efficient cleavage of phospholipid scramblases for the rapid externalization of PS and subsequent efferocytosis. Accordingly, we propose that caspase-7, but not caspase-3, is a bona fide immunologically silent death caspase reinforcing the non-inflammatory nature of apoptosis via EP-CAP.
- Open Access
- 21 February 2025
- Published by Wiley in Cytometry Part A
Investigating T‐Cell Receptor Dynamics Under In Vitro Antibody‐Based Stimulation Using Imaging Flow Cytometry
T cells play a pivotal role in the immune system's response to various conditions. They are activated by antigen‐presenting cells (APCs) via T‐cell surface receptors, resulting in cytokine production and T‐cell proliferation. These interactions occur through the formation of immunological synapses. The advent of imaging flow cytometry has enabled detailed statistical analyses of these cellular interactions. However, the dynamics of T‐cell receptors in response to in vitro stimulation are yet to receive attention, despite it being a crucial aspect of understanding T‐cell behavior. In this article, we explore the responses of T cells to in vitro antibody‐based stimulation without APCs. Specifically, we established a Th1 cell clone, subjected it to a combination of centrifugation‐induced mechanical stress and anti–human CD3 and anti–human CD28 antibody stimulation as the in vitro antibody‐based stimulation, and captured and analyzed bright‐field and fluorescence images of single cells various hours after stimulation using an imaging flow cytometer. Our results indicate distinct temporal dynamics of CD3 and CD28. Notably, CD3 and CD28 relocated on the T‐cell surface immediately after stimulation, with CD3 receptors dispersing after 3.5 h, whereas CD28 remained clustered for 7.5 h. These receptor morphological changes precede cytokine production, suggesting their potential as early indicators of T‐cell activation.
- 21 February 2025
- Published by Wiley in Cytometry Part A
Open AccessInvestigating T‐Cell Receptor Dynamics Under In Vitro Antibody‐Based Stimulation Using Imaging Flow Cytometry
T cells play a pivotal role in the immune system's response to various conditions. They are activated by antigen‐presenting cells (APCs) via T‐cell surface receptors, resulting in cytokine production and T‐cell proliferation. These interactions occur through the formation of immunological synapses. The advent of imaging flow cytometry has enabled detailed statistical analyses of these cellular interactions. However, the dynamics of T‐cell receptors in response to in vitro stimulation are yet to receive attention, despite it being a crucial aspect of understanding T‐cell behavior. In this article, we explore the responses of T cells to in vitro antibody‐based stimulation without APCs. Specifically, we established a Th1 cell clone, subjected it to a combination of centrifugation‐induced mechanical stress and anti–human CD3 and anti–human CD28 antibody stimulation as the in vitro antibody‐based stimulation, and captured and analyzed bright‐field and fluorescence images of single cells various hours after stimulation using an imaging flow cytometer. Our results indicate distinct temporal dynamics of CD3 and CD28. Notably, CD3 and CD28 relocated on the T‐cell surface immediately after stimulation, with CD3 receptors dispersing after 3.5 h, whereas CD28 remained clustered for 7.5 h. These receptor morphological changes precede cytokine production, suggesting their potential as early indicators of T‐cell activation.
- Open Access
- 6 September 2023
- Published by Springer Nature in Communications Biology
- Vol. 6 (1) , 1-11
Time-dependent cell-state selection identifies transiently expressed genes regulating ILC2 activation
The decision of whether cells are activated or not is controlled through dynamic intracellular molecular networks. However, the low population of cells during the transition state of activation renders the analysis of the transcriptome of this state technically challenging. To address this issue, we have developed the Time-Dependent Cell-State Selection (TDCSS) technique, which employs live-cell imaging of secretion activity to detect an index of the transition state, followed by the simultaneous recovery of indexed cells for subsequent transcriptome analysis. In this study, we used the TDCSS technique to investigate the transition state of group 2 innate lymphoid cells (ILC2s) activation, which is indexed by the onset of interleukin (IL)-13 secretion. The TDCSS approach allowed us to identify time-dependent genes, including transiently induced genes (TIGs). Our findings of IL4 and MIR155HG as TIGs have shown a regulatory function in ILC2s activation.
- 6 September 2023
- Published by Springer Nature in Communications Biology
- Vol. 6 (1) , 1-11
Open AccessTime-dependent cell-state selection identifies transiently expressed genes regulating ILC2 activation
The decision of whether cells are activated or not is controlled through dynamic intracellular molecular networks. However, the low population of cells during the transition state of activation renders the analysis of the transcriptome of this state technically challenging. To address this issue, we have developed the Time-Dependent Cell-State Selection (TDCSS) technique, which employs live-cell imaging of secretion activity to detect an index of the transition state, followed by the simultaneous recovery of indexed cells for subsequent transcriptome analysis. In this study, we used the TDCSS technique to investigate the transition state of group 2 innate lymphoid cells (ILC2s) activation, which is indexed by the onset of interleukin (IL)-13 secretion. The TDCSS approach allowed us to identify time-dependent genes, including transiently induced genes (TIGs). Our findings of IL4 and MIR155HG as TIGs have shown a regulatory function in ILC2s activation.